JP and Risk, Let me preface my post by saying t
Post# of 30028
Posted On: 12/16/2014 9:32:48 PM
JP and Risk,
Let me preface my post by saying this: I have followed both of your posts for a while and respect you both. However, as much as it truly "BITES" seeing our PPS at .08, how would you guys go about leading this company if either one of you had the opportunity? How does Gerald profit by continuing to add shares to the float? Do you two truly think he doesn't have the company's and shareholders' best interests at heart? What would benefit him most - a low float or a high float? You guys are making it seem as if he had a billion dollars on the table and turned it down, even though that could be a possibility.
P.S. Here's a scenario for you. He has had offers but turned them all down due to the 'lowballing' by big pharma. Next year, if Lympro truly is the "Gold standard," what types of revenues could it possibly generate/ Control yourselves! That thought is making you salivate isn't? Look at AMYVID! It is generating millions even though it is a piece of garbage - LYMPRO? Oh my! We have no idea what is going on behind the scenes, however, I have no doubt that the Commish and his team are looking to turn our little biotech into a giant. Let's control the emotions a bit and see what unfolds over the next few weeks. I think we will have a definitive answer in terms of the company's outlook and direction by the end of January. Do you guys email the Commish at all? If you don't you should. He responds to my questions - try it! The floodgates are about to open IMO.
Manolo
Let me preface my post by saying this: I have followed both of your posts for a while and respect you both. However, as much as it truly "BITES" seeing our PPS at .08, how would you guys go about leading this company if either one of you had the opportunity? How does Gerald profit by continuing to add shares to the float? Do you two truly think he doesn't have the company's and shareholders' best interests at heart? What would benefit him most - a low float or a high float? You guys are making it seem as if he had a billion dollars on the table and turned it down, even though that could be a possibility.
P.S. Here's a scenario for you. He has had offers but turned them all down due to the 'lowballing' by big pharma. Next year, if Lympro truly is the "Gold standard," what types of revenues could it possibly generate/ Control yourselves! That thought is making you salivate isn't? Look at AMYVID! It is generating millions even though it is a piece of garbage - LYMPRO? Oh my! We have no idea what is going on behind the scenes, however, I have no doubt that the Commish and his team are looking to turn our little biotech into a giant. Let's control the emotions a bit and see what unfolds over the next few weeks. I think we will have a definitive answer in terms of the company's outlook and direction by the end of January. Do you guys email the Commish at all? If you don't you should. He responds to my questions - try it! The floodgates are about to open IMO.
Manolo
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼